Investors Careers FAQ Contact COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS Research Publications and Presentations Henry, et al. Diabetes, 2018. Initial clinical evaluation of VC-01 combination product—a stem cell–derived islet replacement for type 1 diabetes (T1D). Press release. van der Torren, et al. Diabetologia, 2017. Immunogenicity of human embryonic stem cell-derived beta cells. Agulnick, et al. Stem Cell Translational Medicine, 2015. Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Schulz. Stem Cell Translational Medicine, 2015. Concise review: Manufacturing of pancreatic endoderm cells for clinical trials in type 1 diabetes. Rezania, et al. Nature Biotechnology, 2014. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Motté, et al. Am J Physiol Endocrinol Metab, 2014. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts. Rezania, et al. Stem Cells, 2013. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Schulz, et al. PLOS One, 2012. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. Kelly, et al. Nature Biotechnology, 2011. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. McCal, et al. Clinical Science, 2010. Are stem cells a cure for diabetes? Diabetes, Obesity and Metabolism, 2008. Production of ß-cells from human embryonic stem cells. Kroon, et al. Nature Biotechnology, 2008. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cell in vivo. McLean, et al. Stem Cells, 2007. Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. D’Amour, et al. Nature Biotechnology, 2006. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. D’Amour, et al. Nature Biotechnology, 2005. Efficient differentiation of human embryonic stem cells to definitive endoderm. COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS CONTACT Copyright 2021 ViaCyte, Inc. All Rights Reserved Terms of Service Privacy Policy We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT